// Biotech and Pharma Therapeutics
How Can Startups Navigate the Difficult Funding Environment
March 11, 2025 / Biotech Startup Funding / Healthcare Investment Trends / NIH Research Budget Cuts / Clinical Development Strategy
Biotech startups face a tough funding climate due to economic instability and reduced NIH research budgets. Experts advise seeking alternative capital sources, including state-matching funds, crowdfunding, incubators, and strategic partnerships. A strong commercial and clinical development plan is also essential for success.
Medicaid Expansion Cuts Threaten $80B Loss for Healthcare Providers
March 11, 2025 / Medicaid Expansion Cuts / Healthcare Provider Revenue Loss / Federal Healthcare Funding / Medicaid / Hospital Finances
A potential cut in federal Medicaid expansion funding could cause 11 million people to lose coverage, leading to an $80 billion revenue loss for healthcare providers by 2026. Hospitals would face increased uncompensated care costs, straining healthcare access and financial stability.
Veradigm Payer Insights: Close Care Gaps Directly in EHRs for 3,500+ Practices
March 11, 2025 / Veradigm Payer Insights / HER Care Gap Alerts / Healthcare Data Integration / Patient Care
Veradigm Payer Insights now delivers real-time care gap alerts within EHRs for 3,500+ U.S. practices. This integration streamlines workflows, enhances patient outcomes, reduces staff burden, and eliminates manual data retrieval by connecting providers directly with payer insights.
Women spent $8.8B more than men on medications in 2024: 4 takeaways
March 10, 2025 / Prescription Cost Disparity / Women’s Health / Out-of-pocket Medical Costs / Gender Gap in Healthcare / Reproductive Health Expenses
In 2024, U.S. women spent $8.8 billion more than men on prescriptions, largely due to higher healthcare utilization and female-specific treatments. The greatest disparities were in mental health medications, reproductive health, and chronic disease management.
What the HIPAA rulemaking notice means for you
March 11, 2024 / HIPAA Cybersecurity Updates / Healthcare Data Protection / Cybersecurity Risks
New HIPAA rule changes aim to strengthen cybersecurity by mandating encryption, multifactor authentication, and stricter risk management. Healthcare providers and business associates must enhance security measures to prevent breaches, comply with evolving regulations, and protect patient data from cyber threats.
// 4th Industrial Revolution
How One AI Company Is Tackling Gun Violence at Hospitals
March 11, 2025 / AI Gun Detection / Healthcare Security Technology / Hospital Gun Violance Prevention / ZeroEyes AI Security
Hospitals are adopting AI-driven gun detection technology, like ZeroEyes, to enhance security without creating a militarized environment. Using existing cameras, the system identifies firearms before shots are fired, helping protect staff and patients amid rising hospital gun violence.
Smart Solutions for Parkinson’s: The Impact of Wearable Tech Integration
March 11, 2025 / Wearable Technology / Parkinson’s Monitoring / Telemedicine / Neurodegenerative Disease Management
Wearable technology is transforming Parkinson’s care by enabling real-time symptom tracking, personalized treatment adjustments, and predictive analytics. These devices empower patients, enhance remote monitoring, and support telemedicine, improving disease management and overall quality of life.
Revenue Cycle Automation: 3 Considerations For Optimal ROI
March 11, 2025 / Healthcare Revenue Cycle Automation / AI in Medical Billing / Workflow Automation / Financial Clearance
Automation and AI in healthcare revenue cycles can reduce manual tasks, improve financial clearance, and streamline claims processing. By leveraging generative AI and workflow automation, providers can enhance efficiency, minimize denials, and optimize revenue cycle management for better financial sustainability.
Promising AI Applications in Improving Patient Outcomes and Streamlining Healthcare Operations
March 11, 2025 / AI in Healthcare / AI Powered Diagnostics / Patient Engagement / Healthcare Workflow Autmoation
AI is transforming healthcare by improving diagnostics, automating workflows, enhancing cybersecurity, and streamlining revenue cycle management. Key applications include AI-powered clinical documentation, patient engagement, remote monitoring, and risk assessment, ultimately leading to better patient outcomes and operational efficiency.
Korean researchers develop AI to gauge surgery pain
March 10, 2025 / AI in Pain Management / Surgical Pain Assessment AI / Postoperative Pain Prediction / Machine Learning
South Korean researchers developed an AI model that accurately assesses surgical pain by analyzing heart rate, blood pressure, and blood volume. The model improves postoperative pain prediction (93% accuracy) and could enable personalized, objective pain management, even in unconscious patients.
// Business & Markets
Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal
March 11, 2025 / Bristol Myers Squibb Acquisition / CAR T-Cell Therapy Market / Cancer Cell Therapy
Bristol Myers Squibb is acquiring 2seventy bio for $286M, securing full control of Abecma, a CAR T-cell therapy for multiple myeloma. The deal eliminates profit-sharing but comes amid declining U.S. sales and growing competition from Carvykti and emerging therapies.
Junction Raises $18M for Modern Healthcare Infrastructure
March 11, 2025 / Healthcare Infrastructure Modernization / AI in Patient Data Management / Wearable Health Device Integration / Digital Health Transformation
Junction raised $18M to modernize healthcare infrastructure, enabling seamless lab ordering, automated workflows, and wearable device integration. By streamlining data access and reducing administrative burdens, the platform enhances patient adherence and supports the shift toward personalized, home-based care.
Syra Health reports $1.7M growth in population health unit in 2024
March 11, 2025 / Syra Health / Revenue Growth / Population Health Analytics / Behavioral Health Services Expansion / Mental Health Platform / Syrenity
Syra Health’s revenue grew 45% in 2024, driven by a 138% increase in population health services. Investments in behavioral health and data analytics fueled expansion, while the launch of Syrenity, its mental health platform, contributed to higher operating expenses.
Alliance Pharma agrees to increased takeover offer
March 11, 2025 / Alliance Pharma / Acquisition / DBAY Advisors Takeover / UK Pharma Buyout
Alliance Pharma has accepted a £362M ($468M) takeover offer from DBAY Advisors, pending shareholder approval. If finalized, the pharmaceutical company will transition to private ownership, with DBAY financing the acquisition through equity investments and external funding.
Viking Secures 1B Supply of Obesity Pill Candidate With $150M Prepayment Deal
March 11, 2025 / Viking Therapeutics / Obesity Drug / Market Growth / CordenPharma Supply Agreement
Viking Therapeutics secured a $150M prepayment deal with CordenPharma to produce over 1 billion obesity drug VK2735 pills annually. This move ensures future supply chain stability ahead of Phase III trials but may impact Viking’s acquisition prospects.
// Legal & Regulatory
FDA reviewers, inspectors, and investigators excluded from $25K buyout offer
March 10, 2025 / FDA Employment Buyout Exclusion / Federal Workforce Reduction
The HHS is offering a $25,000 buyout for voluntary separations, but FDA reviewers, inspectors, and investigators are excluded. The program aims to downsize the federal workforce, following prior early retirement offers and workforce reduction initiatives.
Merck prevails in US safety litigation over Gardasil HPV vaccine
March 11, 2025 / Merck Gardasil Lawsuit / PV Vaccine Safety Ruling / Gardasil Litigation Decsion / Cancer Prevention
A federal judge ruled in favor of Merck in lawsuits alleging Gardasil caused health issues, citing insufficient evidence of harm. The ruling affects over 200 cases, reinforcing Gardasil’s safety as a key HPV vaccine preventing cervical and other cancers.
CHG Healthcare Announces Acquisition of CareerMD
March 11, 2025 / CHG Healthcare Acquisition / Career MD Physician Recruitment / Medical Career Fairs
CHG Healthcare acquired CareerMD, a career management platform for clinicians. The acquisition enhances CHG’s ability to support physicians and healthcare providers with job placement, career fairs, and digital resources, ensuring long-term workforce development and recruitment solutions.
FDA approves first generic of Xarelto
March 11, 2025 / FDA Xarelto Generic Approval / Rivaroxban Generic Launch / Blood Thinner Medication / Cardiovascular Drug Market
The FDA approved the first generic of Xarelto (rivaroxaban), developed by Taro Pharmaceuticals. This anticoagulant reduces cardiovascular and thrombotic event risks in CAD and PAD patients, increasing accessibility and affordability for those needing blood clot prevention.
California biotech company gets FDA approval for EpiPen alternative for kids
March 7, 2025 / FDA Neffy Approval / Needle-free Epinephrine Spray / EpiPen Alternative
The FDA approved ARS Pharmaceuticals’ Neffy, a needle-free epinephrine nasal spray for children 4 and older with severe allergies. This alternative to EpiPen improves access, reduces injection fears, and may enhance emergency treatment adherence for anaphylaxis.
// Research & Development
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
March 11, 2025 / Biogen Felzartamab Phase 3 / Kidney Transplant Rejection Therapy / Late AMR Clinical Trial
Biogen has initiated the Phase 3 TRANSCEND trial to evaluate felzartamab for late antibody-mediated rejection (AMR) in kidney transplant patients. The study will assess its efficacy in reducing microvascular inflammation and improving kidney allograft survival.
First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet
March 11, 2025 / Gilead Lenacapavir PrEP / HIV Prevention / Phase 1 Lenacapavir Study
Gilead’s Phase 1 study shows promising results for once-yearly lenacapavir, an investigational injectable PrEP option for HIV prevention. The drug maintained effective plasma levels for 52 weeks, was well-tolerated, and could improve adherence compared to daily oral PrEP.
Arvinas gets positive breast cancer data, but finds differentiation a hard sell
March 11, 2025 / Arvinas Pfizer Breast Cancer Drug / Clinical Trial Results / Oncology
“Arvinas and Pfizer’s breast cancer drug, vepdegestrant, showed significant benefits in ESR1-mutated patients but failed to outperform other next-generation estrogen-targeting therapies. While well tolerated, its lack of broader efficacy raises concerns about differentiation in a competitive market.
Semaglutide and tirzepatide potential to transform type 1 diabetes treatment
March 11, 2025 / Semaglutide / Type 1 Diabetes / Tirzepatide Glycemic Control
A study in Diabetes Technology & Therapeutics suggests that off-label semaglutide and tirzepatide significantly lower HbA1c and body weight in type 1 diabetes (T1D) patients. These findings highlight their potential as adjunct therapies to insulin for better glycemic control.
Ascentage’s olverembatinib nabs third breakthrough designation from China’s NMPA
March 11, 2025 / Olverembatinib Breakthrough Therapy / China / Ascentage Pharma Leukemia Drug
China’s NMPA granted Ascentage Pharma’s olverembatinib its third Breakthrough Therapy designation, this time for first-line treatment of Ph+ acute lymphoblastic leukemia (ALL). The third-generation BCR-ABL TKI shows promise in resistant leukemia and gastrointestinal stromal tumors.
// Politics
100 fired CDC employees press RFK Jr. to rehire them, citing shifting guidance
March 11, 2025 / CDC Employee Layoff / Public Health Workforce Cuts / RFK Jr.
Former CDC employees, terminated amid federal agency cuts, are petitioning for reinstatement, citing shifting government guidance and due process concerns. Their roles spanned critical public health areas, and their dismissal raises concerns about workforce stability in disease prevention.
RFK Jr.’s ‘MAHA’ commission meets for the first time — behind closed doors
March 11, 2025 / RFK Jr. / MAHA Commission / US Health Policy Reform / Chronic Disease Prevention
Health Secretary RFK Jr. convened the first closed-door meeting of the “”Make America Healthy Again”” (MAHA) commission, aiming to address chronic health issues. Key federal health and policy leaders participated, though details of discussions remain undisclosed.
Australia’s record gold exports to US set back its case for tariff relief as Trump trade war looms
March 11, 2025 / US Pharma Tariffs / Trump Trade War Impact / Austrlia Export Tariffs
Australia’s record gold exports to the U.S. have weakened its case for tariff exemptions as Trump’s administration imposes new trade restrictions. The 25% tariffs on steel and aluminum may soon expand to pharmaceuticals, potentially disrupting global healthcare supply chains.
Vaccine Skeptic Dave Weldon Is Up To Lead CDC As Measles And Flu Rage
March 10, 2025 / Dave Weldon CDC Nomination / Measles Outbreak / Vaccine Policy
As measles, flu, and bird flu outbreaks surge, vaccine skeptic Dr. Dave Weldon faces Senate confirmation to lead the CDC. His appointment, alongside RFK Jr., raises concerns about public health leadership amid ongoing infectious disease threats.
New Medicare telehealth data drops as industry waits on Congress
March 11, 2025 / Medicare Telehealth Extension / Telehealth Policy / Congress / Virtual Care Reimbursement
As Medicare’s expanded telehealth coverage nears expiration, new data suggests it may lower costs without increasing utilization. Lawmakers debate long-term extensions, with proposals to reduce reimbursement rates to improve affordability and ensure continued access to virtual care.